ArticleContemporary clinical trials communications2026
Strategic risk assessment in oncology: Utilizing single-agent activity to boost combination therapy approvals.
Adetayo Kasim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.